3.44
Cumberland Pharmaceuticals Inc stock is traded at $3.44, with a volume of 23,314.
It is up +0.29% in the last 24 hours and up +18.21% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
See More
Previous Close:
$3.43
Open:
$3.41
24h Volume:
23,314
Relative Volume:
0.30
Market Cap:
$51.46M
Revenue:
$37.79M
Net Income/Loss:
$-10.38M
P/E Ratio:
-4.7123
EPS:
-0.73
Net Cash Flow:
$-1.00M
1W Performance:
+3.93%
1M Performance:
+18.21%
6M Performance:
-38.24%
1Y Performance:
+164.62%
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
2525 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CPIX
Cumberland Pharmaceuticals Inc
|
3.44 | 50.79M | 37.79M | -10.38M | -1.00M | -0.73 |
![]()
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-12-12 | Reiterated | UBS | Neutral |
Feb-01-11 | Reiterated | UBS | Neutral |
Dec-16-10 | Downgrade | UBS | Buy → Neutral |
Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
Aug-17-10 | Reiterated | Morgan Joseph | Buy |
Aug-17-10 | Reiterated | UBS | Buy |
May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
Cumberland Pharmaceuticals Inc. stock prediction for this weekIPO Watch & Reliable Breakout Forecasts - Newser
Analyzing drawdowns of Cumberland Pharmaceuticals Inc. with statistical toolsShare Buyback & Growth Focused Stock Reports - Newser
Key resistance and support levels for Cumberland Pharmaceuticals Inc.Weekly Risk Report & AI Forecast for Swing Trade Picks - Newser
Can Cumberland Pharmaceuticals Inc. hit a new high this monthJuly 2025 Update & Technical Pattern Alert System - Newser
Caroline Young buys Cumberland Pharmaceuticals (CPIX) stock worth $397 By Investing.com - Investing.com Canada
Ranking Cumberland Pharmaceuticals Inc. among high performing stocks via toolsEntry Point & Verified Technical Trade Signals - Newser
Published on: 2025-09-12 16:21:53 - Newser
Advanced analytics toolkit walkthrough for Cumberland Pharmaceuticals Inc.July 2025 Update & Fast Gain Stock Trading Tips - Newser
Kazimi of Cumberland Pharmaceuticals buys $861 in CPIX stock - Investing.com India
Caroline Young buys Cumberland Pharmaceuticals (CPIX) stock worth $397 - Investing.com India
Cumberland Pharmaceuticals director Krogulski buys $4516 in stock - Investing.com
Cumberland Pharmaceuticals director Krogulski buys $4516 in stock By Investing.com - Investing.com Australia
Kazimi of Cumberland Pharmaceuticals buys $861 in CPIX stock By Investing.com - Investing.com Australia
Jones James buys Cumberland Pharmaceuticals (CPIX) shares worth $861 - Investing.com
Market reaction to Cumberland Pharmaceuticals Inc.’s recent newsLayoff News & AI Based Buy and Sell Signals - Newser
Is it too late to sell Cumberland Pharmaceuticals Inc.Recession Risk & Long-Term Capital Growth Strategies - Newser
Published on: 2025-09-12 05:40:00 - Newser
Predicting Cumberland Pharmaceuticals Inc. trend using moving averagesTrade Volume Report & Weekly High Potential Stock Alerts - Newser
Candlestick signals on Cumberland Pharmaceuticals Inc. stock todayJuly 2025 Institutional & Stepwise Swing Trade Plans - Newser
What technical models suggest about Cumberland Pharmaceuticals Inc.’s comebackJuly 2025 Analyst Calls & Short-Term High Return Ideas - Newser
Using Python tools to backtest Cumberland Pharmaceuticals Inc. strategiesJuly 2025 Trends & Short-Term Swing Trade Alerts - Newser
Does Cumberland Pharmaceuticals Inc. show high probability of reboundInsider Selling & Weekly Return Optimization Plans - Newser
What institutional flow reveals about Cumberland Pharmaceuticals Inc.July 2025 Price Swings & Weekly Hot Stock Watchlists - Newser
Applying Elliott Wave Theory to Cumberland Pharmaceuticals Inc.Trade Ideas & Daily Stock Momentum Reports - Newser
Using AI based signals to follow Cumberland Pharmaceuticals Inc.July 2025 PostEarnings & Risk Controlled Stock Pick Alerts - Newser
How to escape a deep drawdown in Cumberland Pharmaceuticals Inc.Recession Risk & Low Risk Entry Point Tips - Newser
Published on: 2025-09-10 11:09:09 - Newser
Technical analysis overview for Cumberland Pharmaceuticals Inc. stockJuly 2025 Final Week & Fast Gain Stock Tips - Newser
Institutional scanner results for Cumberland Pharmaceuticals Inc.Quarterly Portfolio Summary & AI Powered Market Entry Ideas - Newser
Will Cumberland Pharmaceuticals Inc. bounce back from current supportMarket Performance Summary & Reliable Volume Spike Trade Alerts - Newser
Real time social sentiment graph for Cumberland Pharmaceuticals Inc.July 2025 Volume & Daily Growth Stock Tips - Newser
What’s the recovery path for long term holders of Cumberland Pharmaceuticals Inc.Market Trend Report & Community Verified Watchlist Alerts - Newser
Backtesting results for Cumberland Pharmaceuticals Inc. trading strategiesWeekly Volume Report & Free Reliable Trade Execution Plans - Newser
Is it time to cut losses on Cumberland Pharmaceuticals Inc.Dividend Hike & Real-Time Stock Entry Alerts - Newser
Can a trend reversal in Cumberland Pharmaceuticals Inc. lead to recovery2025 Sector Review & Stock Portfolio Risk Control - Newser
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):